Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo treatment for depression tested in small study

NCT ID NCT04846829

First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 27 times

Summary

This study looks at how a single dose of the antidepressant citalopram, given through an IV, affects brain activity when combined with a type of brain stimulation called theta burst stimulation (TBS). Thirty adults with major depression who haven't gotten better with other treatments will receive either the drug or a placebo plus TBS. The goal is to measure changes in depression symptoms and brain signals over 4 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • UCLA Depression Research and Clinic Program

    Los Angeles, California, 90024, United States

Conditions

Explore the condition pages connected to this study.